Program to help under-represented minority students earn doctoral degrees in biomedical sciences
Official title: Bridges to Doctorate Program between Fresno State and UC Davis
Funded at California State University Fresno · NIH-10907620 · Data updated 2026-11-12
This program is designed to help under-represented minority students from Fresno State earn their Master's degree in biomedical sciences and prepare for a Ph.D. at UC Davis, offering personalized support, research training, and networking opportunities to boost their success in the field.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California State University Fresno NIH-funded |
| Lab location | 1 site (Fresno, United States) |
| Project start | August 1, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $57,018 |
| NIH project number | 5T32GM137948-05 |
| Project ID | NIH-10907620 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are under-represented minority students currently enrolled at California State University, Fresno, who are interested in pursuing advanced degrees in biomedical sciences.
✕Less likely to help
Students who are not from under-represented minority backgrounds or those who are not pursuing a career in biomedical sciences may not benefit from this program.
What this research studies
This program aims to support under-represented minority students from California State University, Fresno, in completing a Master's degree in biomedical sciences before advancing to a Ph.D. program at UC Davis. It offers tailored academic and research training plans, enhancing students' professional skills and providing opportunities for networking and participation in research conferences. The initiative focuses on building a strong foundation in research through collaboration with faculty and access to significant research facilities. The goal is to increase the number of URM graduate students in the biomedical sciences field.
Why it matters
Potential benefit: If successful, this program could significantly increase the representation of under-represented minorities in doctoral programs and ultimately in the biomedical research workforce.
How similar studies have gone: Similar programs have shown success in increasing diversity in graduate education and improving outcomes for under-represented minority students in STEM fields.
Where this research is happening
-
California State University Fresno
Fresno, United States Active
Researchers
- Principal investigator: Krishnan, Viswanathan V — California State University Fresno
- Study coordinator: Krishnan, Viswanathan V
Related research
Other NIH-funded projects on the same topics.
-
Surveillance of drug-resistant eye-related bacteria using affordable long-read sequencing
Researchers are testing a low-cost, community-friendly approach to monitor drug-resistant bacteria in settings with limited resources, using eye-drop-related Pseudomonas and local samples.
-
Enzyme-encapsulated protein frameworks to boost multi-step biocatalysis
Researchers are building enzyme-packed, virus-like particles in a solid scaffold to make multi-step chemical reactions faster and reuse the catalysts longer.
-
SEC-MALS instrument to advance biomedical research and education at Fresno State
A new SEC-MALS instrument will be bought to help Fresno State researchers and students measure the size and weight of proteins and other large molecules more accurately.
-
Affordable detection of drug-resistant Pseudomonas in eyedrops and local samples
This project tests low-cost DNA sequencing to find drug-resistant Pseudomonas in contaminated eyedrops and nearby environmental samples for communities with limited lab resources.
-
Investigating how certain compounds can kill harmful parasitic worms
This study is looking at how certain natural compounds called chalcones can help kill harmful worms that affect plants, animals, and even people, with the hope of finding new treatments for these infections.
-
Developing drugs to target proteins involved in Alzheimer's disease
This study is looking at how certain proteins affect Alzheimer's disease and aims to create new small molecules that can help boost good proteins while lowering harmful ones, with the goal of reducing brain plaque buildup, and it's being tested in lab-grown human brain cells.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.